Intellia Therapeutics Bolsa (NASDAQ: NTLA)

Últimas noticias sobre Intellia Therapeutics (NASDAQ:NTLA) Bolsa

INTELLIA THERAPEUTICS INC

Intellia Therapeutics

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

News

ABSI

ACCD

ARKG

ARKK

ARKQ

ARKX

ESLT

ILMN

NTLA

OKLO

PATH

Descubre las recientes decisiones de Ark Invest en energía, defensa y genética, con transacciones millonarias en empresas clave.

Ark Invest adquiere y vende acciones clave en energía, defensa y tecnología genética

Intellia Therapeutics, Inc. - Common Stock

Intellia Therapeutics Inc

Worksport Ltd. (NASDAQ:<a href="https://www.benzinga.com/stock/WKSP#NASDAQ">WKSP</a>) ("Worksport" or the "Company"), a U.S. based manufacturer and innovator of hybrid and clean energy solutions for the light truck, overlanding, and global consumer goods sectors, announced today a transformational leap in performance—achieving a 50% increase in monthly production volume since March 2025, while delivering more than a 100% improvement in gross margins over the past five months. These milestones are underscored by readily increasing demand.
A Fundamentally Transformed Business
Following revenues of $1.5 million in 2023 and $8.5 million in 2024, Worksport is now on track to eclipse $20 million in revenue in 2025. Recently posting <a href="https://www.globenewswire.com/Tracker?data=8eG8DCUu1hXG0D2BhwN8TMUnbJ9kL0G9oI0XIIqLm7EQCL5YwEYqd3dTFUeJCTTfQrCMMrwl6zkLooNK9JKdXs6AFwcYVVPwqWfZiqlGCLMpOT9dG3-KWHR5K8iJJyPxTYJ6CAFwoGNYgeSfiSpHUWH0MNruhET7pTVXlhYcjg8APs_K0WdUaJkNjYbgSvD8nUKO1QuaYi0nE7PuUVEYJvacdsclYpjeQjksGc-kJqC2wXYmxhZhOUMKj3pLC7HeAzVMWaqWSayAS-uaGpnFSxKRiN1bMcvSrAzgiAkhBZI=">multiple consecutive months</a> of record-breaking production, growing market demand, and strong dealer adoption, the Company has rapidly evolved into a high-growth, margin-rich platform. Worksport's expects it can grow its tonneau cover business to excess of $100,000,000 annually within the short term. It sees the potential for its upcoming portable nano-grid system, the <a href="https://www.globenewswire.com/Tracker?data=URspXco2E1HpJpFxjfjbKbUcSjzadF__84Q2tedQnB7ZabhciF6pas-eY7MejzZe3te3hd7aQLiRRTR2RLs0cop6HlW-OBsg8q_EjhU40OaB5t7GJvzdE1Xm5q0Ln4mluEOd1AaIJaP71TdH0KklD8mi8qcs4Bc0_XlRxbdrI7lReUDuNWol_-Vr0pfXRkPdxIbP6GO6PxNRs28Z2ySt-A==">SOLIS and COR</a> to vastly exceed that.

Guidance

WKSP

Worksport Achieves 50% Production Surge And 100%+ Gross Margin Growth Since March 2025; Projects $20M Revenue In 2025

Goldman Sachs analyst Lizzie Dove initiates coverage on Wynn Resorts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WYNN#NASDAQ">WYNN</a>) with a Buy rating and announces Price Target of $122.

Price Target

Initiation

Analyst Ratings

WYNN

Goldman Sachs Initiates Coverage On Wynn Resorts with Buy Rating, Announces Price Target of $122

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/07081659/CS.jpeg" alt="" class="wp-image-15373" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/07081659/CS.jpeg 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/07081659/CS-300x200.jpeg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/07081659/CS-768x512.jpeg 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
The operator of an app allowing users to directly convert images to PDF files from their smartphones hopes to sell investors on its growing profits and strong margins 
<h4 class="wp-block-heading">Key Takeaways:</h4>
<ul class="wp-block-list">
<li>Intsig has filed to list in Hong Kong, boasting nearly 30% annual profit growth over the last three years and gross profit margins of around 80%</li>
<li>CamScanner, an app allowing users to create PDF files directly from images on their phones, contributes about three-quarters of the company's revenue</li>
</ul>
Many people around the world may have used CamScanner, an application that converts documents into PDF files using photos on a smartphone. But far fewer may know the app is operated by China's&nbsp;Intsig Information Co. Ltd.&nbsp;(688615.SH), whose founder and Chairman Zhen Lixin has worked in some top firms, including oil major Sinopec, where he was an electrical engineer, and Motorola, which he joined in 2000 before setting up Intsig in 2006.
Zhen's company went through various products before hitting its stride in 2010 with CamScanner, which has grown since then to contribute over 70% of its revenue. Intsig listed on Shanghai's Nasdaq-style STAR Market last year, where it's currently valued at a hefty figure of more than 20 billion yuan ($2.8 billion). Now, the company is trying to cash in on the recent frenzy by firms listed on China's domestic-focused markets in Shanghai and Shenzhen to make a second listing in Hong Kong targeting global investors.
CamScanner bills itself as the world's largest image-to-text processing product maker by user base, according to its&nbsp;<a href="https://www1.hkexnews.hk/app/sehk/2025/107479/documents/sehk25062600499.pdf">listing document</a>filed late last month. The app has ranked at the top of the free efficiency apps list in the Apple app store "at various times" since 2013, it said, citing third-party research. With over 1 billion users across 200 countries and support in 52 languages, it says it is one of the few global apps to consistently grow at an annual rate of more than 20% for more than 15 years.
<h4 class="wp-block-heading">AI enhancements</h4>
The company has taken advantage of the recent AI boom to integrate a wide range of new features into its flagship product, with names like AI Magic Pro, AI Smart Erasure, and AI Sign. CamScanner accounted for 77% of Intsig's revenue last year, with the figure rising to 81% in the first quarter of 2025. The company's portfolio also includes other consumer-focused (2C) products like business card reader CamCard and corporate credit data app Qixinbao.
For business customers (2B), Intsig offers products like TextIn and Qixin Insight, though those account for only about 16% of its revenue. Gross profit margins for 2B products come in around 60%, notably lower than more than 80% from 2C products.
While STAR Market-listed companies are often money-losing startups, Intsig hardly fits that mold. To the contrary, the company boasts strong revenue and profits, which are both growing steadily. Its revenue grew at an average annual rate of more than 20% between 2022 and 2024, reaching 1.44 billion yuan ($201 billion) last year. Its net profit grew about 28% annually over that period to reach 400 million yuan last year. That growth continued in this year's first quarter, with its profit rising 29.4% year-on-year to 116 million yuan during the three-month period. Its gross profit margins also consistently exceeded 80% during that time.&nbsp;
<h4 class="wp-block-heading">Fierce competition</h4>
While things look good for the company right now, Intsig's listing document also outlines a number of risks it faces. It points out the rapid evolution of AI technology could erode its competitiveness if it fails to keep pace. Despite its strong position in its niche, the company holds just 2.2% of the global 2C efficiency AI product segment, showing it faces stiff competition from both domestic and international rivals. The company's possession of extensive user data also raises the risks of data breaches and privacy compliance – issues that are often more difficult for smaller, less experienced companies to handle.&nbsp;
To maintain its edge, Intsig spends heavily on R&amp;D, whose costs have risen from 279 million yuan in 2022 to 390 million yuan in 2024, equal to 27% of its revenue last year. Moreover, with about one-third of revenue coming from overseas, Intsig faces the task of managing foreign exchange risk.
Shanghai- and Shenzhen-listed companies making second IPOs in Hong Kong has become a major recent trend, but the latter are often valued lower than the former. That means that while Intsig is valued relatively high by Shanghai investors, with a current market value of about 22 billion yuan, or roughly $3 billion, it may not get such a strong valuation from global investors who are a major force in Hong Kong.&nbsp;
Among such dual listings, four out of five to debut from May onward were up from their Hong Kong IPO prices as of June 27, including electric vehicle battery giant CATL, which sold its Hong Kong shares at a 7% discount to their Shenzhen price. CATL's strong business prospects and a relatively small float for its Hong Kong listing have led the Hong Kong stock to trade at a premium to the company's Shenzhen shares. By June 27, its Hong Kong stock price had surged 24% from the IPO price to trade at a substantial 20% premium to its Shenzhen share price. But such a premium is extremely rare.
<h4 class="wp-block-heading">Mixed performance for new dual listings</h4>
Instead, the opposite is more commonly the case, with the Hong Kong shares of most dual listed companies trading at discounts of around 20% to their Shanghai- and Shenzhen-listed prices. Hengrui Pharmaceuticals and Sanhua Intelligent Controls are more typical of the group. The former is up 26% from its Hong Kong IPO price and the latter is up 8%, but both still trade at discounts to their prices on Mainland Chinese markets. Hong Kong-listed shares of leading condiment maker Haitian Flavouring have fallen 3.4% since their listing, and also trade at a 20% discount to their Shanghai-listed shares.
Intsig listed on the Shanghai STAR Market in September 2024 by selling shares for 55.18 yuan apiece. The price soared past 100 yuan on its debut and later climbed to more than 500 yuan on a wave of speculative buying. It has come down since then to currently trade at around 150 yuan, giving it a price-to-earnings (P/E) ratio that still looks relatively high at about 51 times. The company's appeal to Hong Kong investors is likely to hinge on the size of the discount it offers relative to its Shanghai share price.

Asia

IPOs

Global

Opinion

Trading Ideas

Intsig Files For Hong Kong IPO To Court Global Investors

A fresh controversy is brewing in China&#8217;s intensely competitive artificial intelligence market as Huawei Technologies&#8217; AI research arm has firmly rejected allegations of plagiarizing elements from an Alibaba Group Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) model. This denial comes as Alibaba&#8217;s stock traded lower on Monday. 
The accusations, stemming from a paper released on GitHub on July 4 by HonestAGI, claim &#8220;extraordinary correlation&#8221; between Huawei&#8217;s recently open-sourced Pangu Pro Moe model and Alibaba&#8217;s established Qwen 2.5 14B. This development further heats up the Chinese AI landscape, which has seen a price war initiated by startups like DeepSeek earlier in 2024.
<h2 class="wp-block-heading">Huawei&#8217;s Noah&#8217;s Ark Lab Issues Strong Denial</h2>
Huawei&#8217;s Noah&#8217;s Ark Lab issued a statement Saturday to Reuters, asserting that its Pangu Pro Moe (Mixture of Experts) model was developed and trained independently.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/tech/25/07/46250853/alibabas-ai-and-cloud-moves-have-sparked-28-stock-rebound" rel="noreferrer noopener">Alibaba&#8217;s AI And Cloud Moves Have Sparked 28% Stock Rebound</a>
The denial came after HonestAGI published a paper on GitHub on Friday, claiming that Huawei&#8217;s model showed &#8220;extraordinary correlation&#8221; with Alibaba&#8217;s Qwen 2.5 14B model.
The paper argued the model appeared &#8220;upcycled&#8221; rather than trained from scratch, raising concerns about possible copyright violations, fabricated technical claims, and misrepresented training investments.
Noah&#8217;s Ark Lab rejected the claims, stating the model was not incrementally trained on others&#8217; work and featured original architectural and technical innovations. The lab added that Pangu Pro Moe is the first large model fully built on Huawei&#8217;s Ascend chips.
Huawei&#8217;s Ascend chips are a series of AI processors designed by Huawei for AI training and inference, aiming to compete with leading chipmakers like Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>).
<h2 class="wp-block-heading">China&#8217;s Fierce AI Market And Price Wars</h2>
The allegations underscore the intense competition within China&#8217;s booming AI market. Chinese AI startup DeepSeek ignited a <a href="https://www.benzinga.com/markets/asia/25/04/45015548/baidu-goes-aggressive-chinas-in-ai-price-war-with-alibaba-deepseek">domestic price war</a> in 2024 by introducing affordable AI models, prompting tech giants like Alibaba to follow suit and further intensifying the competitive landscape.
<h2 class="wp-block-heading">Alibaba&#8217;s AI And Cloud Expansion</h2>
Alibaba stock surged 28% year-to-date, driven by increased investor confidence in China&#8217;s tech sector, strong earnings reports, and a push into artificial intelligence. 
Alibaba Cloud is <a href="https://www.benzinga.com/markets/tech/25/07/46215371/alibaba-cloud-opens-third-malaysia-data-center-plans-second-in-philippines" target="_blank" rel="noreferrer noopener">rapidly expanding overseas</a>, adding new data centers in Malaysia, South Korea, and the Philippines as part of a global push. These expansions were announced in the first half of 2025, with a third data center in Malaysia launched on July 1, 2025, and a second in the Philippines planned for October 2025.
CEO Eddie Wu has made globalization a core strategy, with plans to grow Alibaba&#8217;s cloud presence across Asia, Europe, the Middle East, and the Americas. The company will launch a global AI competency center in Singapore and expand its Qwen AI models to international data hubs by 2025. 
Backing its ambitions, Alibaba has committed $52 billion over three years to cloud and AI infrastructure, partnering with Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) and Nvidia.
Price Action:&nbsp;BABA shares are trading lower by&nbsp;1.37% to&nbsp;$107.40 premarket at&nbsp;last check on Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46246152/iphone-sales-bounce-back-in-china-but-huawei-and-xiaomi-intensify-pressure" target="_blank" rel="noreferrer noopener">iPhone Sales Bounce Back In China, But Huawei And Xiaomi Intensify Pressure</a></li>
</ul>
Photo by Mamun_Sheikh via Shutterstock

Tech

Media

BABA

MSFT

NVDA

Huawei-Alibaba Clash Heats Up On AI Model Plagiarism Allegations

Following a $172 million public equity raise and conversion of its balance sheet from Bitcoin to Ethereum, Bit Digital has accumulated over 100K ETH to become one of the largest corporate treasury companies in the world led under Ethereum veteran Sam Tabar
NEW YORK, July 7, 2025 /PRNewswire/ -- Bit Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTBT#NASDAQ">BTBT</a>) ("Bit Digital" or the "Company"), today announced the completion of its transition to an Ethereum treasury strategy. Following the close of its recent underwritten public offering, the Company raised approximately $172 million in gross proceeds and has deployed the net capital to purchase Ethereum ("ETH"). Additionally, Bit Digital sold approximately 280 BTC and used the proceeds to purchase additional ETH.
Prior to the offering, Bit Digital held 24,434 ETH as of March 31, 2025. Following the additional ETH acquisitions funded by the net proceeds of the public offerings and the sale of its bitcoin position,&nbsp;the Company has accumulated approximately 100,603 ETH.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

BTBT

Bit Digital Raises $172M In Public Offering, Converts Treasury By Selling ~280 Bitcoin To Acquire ~100,603 ETH

Blackstone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>) and Allegiant Travel Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGT#NASDAQ">ALGT</a>) today announced that funds affiliated with Blackstone Real Estate have agreed to acquire Sunseeker Resort Charlotte Harbor from Allegiant for $200 million.
The transaction is expected to close in the third quarter of 2025, subject to satisfying customary conditions.

ALGT

BXMT

Blackstone And Allegiant Travel Says Funds Affiliated With Blackstone Real Estate To Acquire Sunseeker Resort Charlotte Harbor From Allegiant For $200M

Evercore ISI Group analyst Mark Mahaney initiates coverage on Chime Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHYM#NASDAQ">CHYM</a>) with a Outperform rating and announces Price Target of $38.

CHYM

Evercore ISI Group Initiates Coverage On Chime Financial with Outperform Rating, Announces Price Target of $38

MLGO

MicroAlgo Announces The Development Of A Grover-Based Quantum Algorithm Technology Designed To Find Pure Nash Equilibria In Graphical Games

State Street Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STT#NYSE">STT</a>) will release earnings results for the second quarter, before the <a href="https://www.benzinga.com/quote/stt/earnings">opening bell on Tuesday, July 15.</a>
Analysts expect the Boston, Massachusetts-based company to report quarterly earnings at $2.39 per share, up from $2.15 per share in the year-ago period. State Street projects to report quarterly revenue at $3.33 billion, compared to $3.19 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On July 1, State Street increased its quarterly cash dividend from 76 cents to 84 cents per share.
State Street shares gained 0.8% to close at $110.31 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/stt/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Truist Securities analyst David Smith maintained a Buy rating and raised the price target from $112 to $122 on July 3, 2025. This analyst has an accuracy rate of 72%.</li>
<li>Goldman Sachs analyst Alexander Blostein maintained a Buy rating and increased the price target from $98 to $111 on July 2, 2025. This analyst has an accuracy rate of 72%.</li>
<li>Evercore ISI Group analyst Glenn Schorr maintained an Outperform rating and raised the price target from $102 to $115 on July 2, 2025. This analyst has an accuracy rate of 71%.</li>
<li>Citigroup analyst Keith Horowitz maintained a Neutral rating and increased the price target from $100 to $115 on July 2, 2025. This analyst has an accuracy rate of 77%.</li>
<li>Morgan Stanley analyst Betsy Graseck maintained an Overweight rating and raised the price target from $110 to $114 on July 1, 2025. This analyst has an accuracy rate of 61%.</li>
</ul>
Considering buying STT stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/STT/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="577" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07023458/image-54-1024x577.png" alt="" class="wp-image-974116" style="width:694px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07023458/image-54-1024x577.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07023458/image-54-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07023458/image-54-768x433.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07023458/image-54.png 1155w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46243448/cramer-doesnt-recommend-titan-international-joby-aviation-soars-after-milestone-flight">Cramer Doesn&#8217;t Recommend Titan International, Joby Aviation Soars After Milestone Flight</a> </li>
</ul>
Photo via Shutterstock

Earnings

State Street Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Jefferies analyst Laurence Alexander downgraded the rating for MP Materials Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>) from Buy to Hold but raised the price target from $32 to $33. MP Materials shares closed at $31.84 on Thursday. <a href="https://www.benzinga.com/quote/MP/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Surinder Thind downgraded ASGN Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASGN#NYSE">ASGN</a>) from Hold to Underperform and lowered the price target from $53 to $42. ASGN shares closed at $52.84 on Thursday. <a href="https://www.benzinga.com/quote/ASGN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities analyst Michael Jacks downgraded Stellantis N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) from Buy to Neutral and cut the price target from&nbsp;$16.5&nbsp;to&nbsp;$11.75. Stellantis shares closed at $10.31 on Thursday. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Alex Scott downgraded Chubb Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CB#NYSE">CB</a>) from Overweight to Equal-Weight and lowered the price target from $321 to $298. Chubb shares closed at $283.80 on Thursday. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying ASGN stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/ASGN/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="600" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07082511/image-64-1024x600.png" alt="" class="wp-image-974694" style="width:606px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07082511/image-64-1024x600.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07082511/image-64-300x176.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07082511/image-64-768x450.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07082511/image-64.png 1115w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46243448/cramer-doesnt-recommend-titan-international-joby-aviation-soars-after-milestone-flight">Cramer Doesn&#8217;t Recommend Titan International, Joby Aviation Soars After Milestone Flight</a> </li>
</ul>
Photo via Shutterstock

Downgrades

ASGN

OSCR

SNDK

STLA

VOYG

This ASGN Analyst Turns Bearish; Here Are Top 4 Downgrades For Monday

SEALSQ Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAES#NASDAQ">LAES</a>), a global leader in Post-Quantum and Quantum-resilient cybersecurity solutions, today announced its Quantum Investment Fund has been increased from $20 million to over $35 million. The increase is aimed at accelerating the convergence of Quantum, Post-Quantum cryptography, edge security, satellite communications, and secure identity infrastructure into a seamless and secure ecosystem for the next digital era.
Strategic Investments executed so far and How They Interconnect
<ul>
<li>Quantix Edge (Spain): SEALSQ, in conjunction with its parent company, WISeKey International Holding Ltd ("WISeKey") ((SIX: WIHN, NASDAQ:<a href="https://www.benzinga.com/stock/WKEY#NASDAQ">WKEY</a>), a leading global cybersecurity, blockchain, and IoT company, has committed to invest approximately $12.0 million (€10.2M) to co-develop a Post-Quantum Semiconductor Center in Murcia, in collaboration with the Spanish government's SETT.ES program (€20M support). This facility will design and manufacture Post-Quantum and Quantum-enhanced chips, forming the hardware foundation of SEALSQ's secure ecosystem.</li>
<li>WeCan Group (Switzerland): Through an approximately $3.5 million investment for a 28% stake, SEALSQ is integrating Post-Quantum digital identity and KYC capabilities into financial services. WeCan's blockchain-based solutions will interface securely with SEALSQ hardware using Quantum-resistant cryptographic keys.</li>
<li>IC'Alps (France): The approximately $14.7 million (€10 million cash and €2.5 million stock, not including any potential earn-out consideration) acquisition of this ASIC design firm gives SEALSQ full control over custom silicon development, enabling Quantum-ready secure elements and chips that power everything from IoT devices to space-grade hardware. These ASICs are being optimized to run Post-Quantum algorithms such as CRYSTALS-Kyber.</li>
<li>WISeSat.Space (Global): A $10 million investment is being used to deploy Post-Quantum-secured communication satellites. These satellites form part of the WISeSat.Space constellation, enabling encrypted communication between remote IoT nodes, financial networks, and critical infrastructure, even in areas without terrestrial connectivity.</li>
<li>ColibriTD (France): A strategic initial investment of $100,000 stake in this Quantum cryptography startup ensures access to next-gen algorithms and protocols. ColibriTD is working on integrating Quantum Key Distribution (QKD) and hybrid PQC models into SEALSQ's infrastructure, closing the loop from hardware to satellite to software.</li>
</ul>
 &nbsp;

LAES

SEALSQ Increases Quantum Investment Fund From $20M To Over $35M

Barclays analyst Alex Scott upgrades RenaissanceRe Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNR#NYSE">RNR</a>) from Underweight to Equal-Weight and raises the price target from $231 to $256.

Upgrades

Barclays Upgrades RenaissanceRe Holdings to Equal-Weight, Raises Price Target to $256

Across the recent three months, 23 analysts have shared their insights on Datadog (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>), expressing a variety of opinions spanning from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">12</td>
<td align="right">8</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">8</td>
<td align="right">7</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $133.96, a high estimate of $175.00, and a low estimate of $115.00. This current average has decreased by 7.0% from the previous average price target of $144.04. 
<img src="https://www.benzinga.com/files/images/story/2025/1751893336_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Datadog. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Koji Ikeda</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$175.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Brad Reback</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$135.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Koji Ikeda</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$150.00</td>
<td>$138.00</td>
</tr>
<tr>
<td>Mike Cikos</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$140.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Daniel Ives</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$140.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Karl Keirstead</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$140.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Matthew Hedberg</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$119.00</td>
<td>$119.00</td>
</tr>
<tr>
<td>Daniel Ives</td>
<td>Wedbush</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$140.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Steve Koenig</td>
<td>Macquarie</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$140.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Thomas Blakey</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$134.00</td>
<td>$134.00</td>
</tr>
<tr>
<td>Karl Keirstead</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$125.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Andrew Nowinski</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$115.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Kingsley Crane</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Buy</td>
<td>$145.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Blair Abernethy</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$150.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Mike Cikos</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$130.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$128.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Gil Luria</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Buy</td>
<td>$125.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Blair Abernethy</td>
<td>Rosenblatt</td>
<td>Lowers</td>
<td>Buy</td>
<td>$150.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$125.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Sanjit Singh</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$115.00</td>
<td>$143.00</td>
</tr>
<tr>
<td>Karl Keirstead</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$120.00</td>
<td>$164.00</td>
</tr>
<tr>
<td>Patrick Colville</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Outperform</td>
<td>$125.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Gil Luria</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Buy</td>
<td>$115.00</td>
<td>$165.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Datadog. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Datadog compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Datadog's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Datadog's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/DDOG/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Datadog analyst ratings.</a>
<h2>About Datadog</h2>
Datadog is a cloud-native company that focuses on analyzing machine data. The firm's product portfolio, delivered via software as a service, allows a client to monitor and analyze its entire IT infrastructure. Datadog's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to utilize it for a variety of applications throughout their businesses.
<h3>Datadog: Financial Performance Dissected</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Datadog's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 24.59%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 3.24%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Datadog's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 0.88%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Datadog's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.42%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.64, Datadog adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

DDOG

Expert Outlook: Datadog Through The Eyes Of 23 Analysts

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/07081930/Moore-Threads-0707-900x600-1.png" alt="" class="wp-image-15376" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/07081930/Moore-Threads-0707-900x600-1.png 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/07081930/Moore-Threads-0707-900x600-1-300x200.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/07081930/Moore-Threads-0707-900x600-1-768x512.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
The GPU maker hopes to benefit from China's drive to develop its domestic chip industry, as it navigates growing obstacles from U.S. sanctions 
<h4 class="wp-block-heading">Key Takeaways:</h4>
<ul class="wp-block-list">
<li>Moore Threads has filed for an A-share IPO, reporting combined losses of 5 billion yuan over the last three years on modest but fast-growing revenue</li>
<li>The company hopes to become a leader in China's GPU market, which is expected to grow tenfold by 2029 as domestic chips increasingly replace foreign imports</li>
</ul>
It may be just five years old, but Moore Threads Technology is already looking to Beijing for more than $1 billion in assistance as tries to become an key Chinese supplier of the graphics processing units (GPU) that are central to powering AI applications. The high-tech chipmaker <a href="https://www.sse.com.cn/listing/renewal/ipo/index_listing_detail.shtml?auditId=2098">filed for an IPO</a> on China's A-share market last week, where it's almost certain to attract interest from the country's vast field of state-run investors eager to assist Beijing in the country's quest for self-sufficiency in key technologies.
Moore Threads is, in many ways, a product of the billions of dollars that China is pumping into such key tech sectors. It was founded at the height of U.S. sanctions against China, the same year that Washington imposed sweeping bans on leading tech firm Huawei. Its founders believe the company could benefit from new opportunities for Chinese companies to sell products like GPUs, which now mostly come from foreign suppliers and are key for development of AI and other sophisticated computing applications.
Such ambitions come with their own risks, as Moore Threads found out in 2023 when it was subject to U.S. restrictions similar to those placed on Huawei. That action bars the company from manufacturing its products in partnership with companies like TSMC, a contract chip maker used by most of the world's most cutting-edge chip designers to make their products.
In China's policy-driven climate, companies like Moore Threads are receiving preferential treatment that allows them to list ahead of other firms that have often waited longer, reflecting Beijing's desire to channel limited IPO funds to candidates in high-priority areas.
The company's&nbsp;<a href="https://www.sse.com.cn/listing/renewal/ipo/index_listing_detail.shtml?auditId=2078">prospectus</a>&nbsp;shows it aims to raise 8 billion yuan ($1.1 billion), a substantial amount that appears designed to capitalize on strong investor demand for anything AI-related, including makers of the AI chips. On the same day, rival&nbsp;MetaX&nbsp;also&nbsp;<a href="https://static.sse.com.cn/stock/disclosure/announcement/c/202506/002046_20250617_KR95.pdf">filed</a>&nbsp;for a smaller IPO to raise 3.9 billion yuan, while&nbsp;Zhaoxin Semiconductor, a company focused on central processing units (CPU), also filed last month to raise 4.2 billion yuan.
Like many of its peers, Moore Threads was founded by former employees of leading global chip firms. Co-founder and CEO Zhang Jianzhong previously served as global vice president and China general manager of&nbsp;Nvidia&nbsp;(NVDA.US), whose status as the global leader in GPUs has transformed it into one of the world's most valuable companies. Another co-founder, Zhang Yubo, was a senior architect at Nvidia's U.S. operation.
According to corporate registration site Tianyancha, Moore Threads has raised at least 4.5 billion yuan to date through six funding rounds, though that list may be incomplete. Its investors include HongShan, formerly known as Sequoia China, as well as Shenzhen Capital Group, and internet giants Tencent and ByteDance. The company was valued at 25.5 billion yuan, according to a June report from local media Leifeng, which didn't specify when it attained that value.
<h4 class="wp-block-heading">Mounting losses</h4>
Despite its relatively high valuation, Moore Threads' youth is apparent in its modest, albeit fast-growing, revenue. The company generated just 438 million yuan last year, though that was more than triple the 124 million yuan for 2023, and light years ahead of its 46 million yuan in 2022, according to its prospectus. Meanwhile, its losses are massive but narrowing, falling from 1.84 billion yuan in 2022, to 1.67 billion yuan the next year and 1.49 billion yuan in 2024
Such losses are common among young chip companies due to the very high costs of GPU development. Moore Threads spent a combined 3.8 billion yuan on R&amp;D in the last three years, including 1.4 billion yuan in 2024 alone.
The company develops chips for data centers, which are increasingly used to power AI applications. It also makes chips for consumer devices such as smartphones and PCs. While Moore Threads didn't break down revenue by segment, data center chips are widely believed to contribute the majority of its revenue and represent the company's primary focus.
Moore Threads has developed four generations of GPU products in its data center segment, including the latest S500, which the company claims is competitive with Nvidia's A100 in some areas. While that looks less impressive since the A100 is five years old, it still makes Moore Threads among the most technologically advanced Chinese GPU developers.
Moore Threads believes the current environment will work to its advantage, dedicating significant space in its prospectus to explaining how Chinese localization policies will drive increased adoption of domestically produced GPUs. The company cited third-party research showing China's data center and cloud GPU market is expected to grow roughly tenfold from 99.7 billion yuan in 2024 to 1 trillion yuan in 2029, with domestic products increasingly replacing imports.
Research from other companies supports such projections. Morgan Stanley said in a May client note that domestically made GPUs could generate 287 billion yuan in sales by 2027, capturing 70% of the Chinese market, up from 30% last year.
Moore Threads is hardly the only company hoping to capitalize on the shift to domestic production. Others jumping on the GPU bandwagon include heavyweights like Huawei, as well as mid-tier players such as&nbsp;Cambricon&nbsp;(688256.SS),&nbsp;Hygon&nbsp;(688041.SH), MetaX,&nbsp;Biren,&nbsp;Iluvatar CoreX, and Tencent-backed&nbsp;Enflame. Major internet companies have also launched their own chip units, including Alibaba's T-Head and Baidu's Kunlun.
Many of Moore Threads' peers are also pursuing IPOs. In addition to MetaX, companies including Enflame and Biren have filed for the "tutoring process" that's a requisite part of China's IPO process. Reuters reported last month that Biren has shifted its focus to a Hong Kong listing after initially filing for an A-share IPO, partly due to stricter regulatory requirements on the Mainland.
A major challenge facing Chinese developers is U.S. sanctions like the ones Moore Threads faced in 2023, preventing it from producing its chips at the world's most advanced foundries. Such steps have forced Chinese companies to compete for limited advanced manufacturing capacity at leading domestic foundry SMIC, whose own expansion is also being constrained by U.S. export controls on essential chipmaking equipment.
Moore Threads acknowledged that the U.S. restrictions have forced it to find domestic substitutions and take other measures. The company did not reveal which foundry it currently uses to make its chips, or whether it faces other manufacturing challenges.
A successful IPO would provide Moore Threads with the cash it needs to stay competitive, with much of the funds earmarked for R&amp;D, according to the prospectus. Investors looking for profits anytime soon might want to temper their expectations, since the company warned that it "may continue to incur losses." Still, such losses are unlikely to deter big state-backed investors, which are more likely to consider longer-term profit potential and helping Beijing to reach its policy objectives.

Moore Threads Seeks IPO Amid China's Drive For Chip Independence

General

Bio-Rad  Announces Launch Of New Droplet Digital PCR Platforms

ASGN (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASGN#NYSE">ASGN</a>) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $56.4, a high estimate of $75.00, and a low estimate of $42.00. A 31.43% drop is evident in the current average compared to the previous average price target of $82.25. 
<img src="https://www.benzinga.com/files/images/story/2025/1751893328_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The standing of ASGN among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Surinder Thind</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$42.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$56.00</td>
<td>-</td>
</tr>
<tr>
<td>Joseph Vafi</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Hold</td>
<td>$55.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Kevin Mcveigh</td>
<td>UBS</td>
<td>Lowers</td>
<td>Sell</td>
<td>$54.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Tobey Sommer</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$75.00</td>
<td>$105.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to ASGN. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of ASGN compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of ASGN's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of ASGN's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/ASGN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on ASGN analyst ratings.</a>
<h2>Discovering ASGN: A Closer Look</h2>
ASGN Inc is a provider of information technology (IT) services and professional solutions, including technology, creative, and digital, across the commercial and government sectors. It operates through two segments, Commercial and Federal Government. The Commercial Segment, which generates the majority of the revenue, provides consulting, creative digital marketing, and permanent placement services to Fortune 1000 clients and mid-market companies. The Federal Government Segment provides mission-critical solutions to the Department of Defense, intelligence agencies, and civilian agencies.
<h3>Understanding the Numbers: ASGN's Finances</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Negative Revenue Trend: Examining ASGN's financials over 3M reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately -7.69% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: ASGN's net margin excels beyond industry benchmarks, reaching 2.16%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): ASGN's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 1.17%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.59%, the company showcases effective utilization of assets.
Debt Management: ASGN's debt-to-equity ratio is below the industry average at 0.75, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Basics of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 5 Analysts Discuss ASGN Stock

In the last three months, 5 analysts have published ratings on MP Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>), offering a diverse range of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $28.8, a high estimate of $38.00, and a low estimate of $18.00. Marking an increase of 12.5%, the current average surpasses the previous average price target of $25.60. 
<img src="https://www.benzinga.com/files/images/story/2025/1751893319_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The standing of MP Materials among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Laurence Alexander</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$33.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Ben Kallo</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$38.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Carlos De Alba</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$34.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Bill Peterson</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$18.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Bill Peterson</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$21.00</td>
<td>$22.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to MP Materials. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of MP Materials compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of MP Materials's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/MP/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on MP Materials analyst ratings.</a>
<h2>About MP Materials</h2>
MP Materials Corp is the producer of rare earth materials in the Western Hemisphere. The company owns and operates the Mountain Pass Rare Earth Mine and Processing Facility, the only rare earth mining and processing site of scale in North America. The company is also developing a rare earth metal, alloy, and magnet manufacturing facility in Fort Worth, Texas. The company's operations are organized into two reportable segments: Materials and Magnetics.
<h3>Breaking Down MP Materials's Financial Performance</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: Over the 3M period, MP Materials showcased positive performance, achieving a revenue growth rate of 24.91% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Net Margin: MP Materials's net margin excels beyond industry benchmarks, reaching -37.24%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of -2.17%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): MP Materials's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of -0.96%, the company showcases efficient use of assets and strong financial health.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 0.88, caution is advised due to increased financial risk.
<h2>How Are Analyst Ratings Determined?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: MP Materials Through The Eyes Of 5 Analysts

During the last three months, 11 analysts shared their evaluations of EQT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQT#NYSE">EQT</a>), revealing diverse outlooks from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for EQT, presenting an average target of $58.09, a high estimate of $69.00, and a low estimate of $35.00. Marking an increase of 11.01%, the current average surpasses the previous average price target of $52.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1751893311_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A clear picture of EQT's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Betty Jiang</td>
<td>Barclays</td>
<td>Announces</td>
<td>Overweight</td>
<td>$65.00</td>
<td>-</td>
</tr>
<tr>
<td>Leo Mariani</td>
<td>Roth Capital</td>
<td>Announces</td>
<td>Buy</td>
<td>$69.00</td>
<td>-</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$63.00</td>
<td>$59.00</td>
</tr>
<tr>
<td>Cameron Bean</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$62.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$48.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$64.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Devin McDermott</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$65.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$35.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$54.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Mike Scialla</td>
<td>Stephens &amp; Co.</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$57.00</td>
<td>$59.00</td>
</tr>
<tr>
<td>Cameron Bean</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$57.00</td>
<td>$54.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to EQT. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of EQT compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of EQT's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of EQT's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/EQT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on EQT analyst ratings.</a>
<h2>Get to Know EQT Better</h2>
EQT is an independent natural gas production company. It focuses its operations in the cores of the Marcellus and Utica shales, located in the Appalachian Basin in the Eastern United States. Its main customers include marketers, utilities, and industrial operators in the Appalachian Basin. The company has three reportable segments in production, gathering, and its transmission segment, which is now an operated joint venture with Blackstone. All the firm's operating revenue is generated in the US, with most revenue flowing from the Marcellus Shale field and through the sale of natural gas.
<h3>EQT's Economic Impact: An Analysis</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Positive Revenue Trend: Examining EQT's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 85.24% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. When compared to others in the Energy sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: EQT's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 10.01%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): EQT's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 1.17%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): EQT's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.61%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: EQT's debt-to-equity ratio is below the industry average at 0.41, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Significance of Analyst Ratings Explained</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: EQT Through The Eyes Of 11 Analysts

Evercore ISI Group analyst Steve Sakwa upgrades Equity Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQR#NYSE">EQR</a>) from In-Line to Outperform and raises the price target from $74 to $75.

Evercore ISI Group Upgrades Equity Residential to Outperform, Raises Price Target to $75

Travelers Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>) has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $275.45, a high estimate of $303.00, and a low estimate of $247.00. Observing a 2.47% increase, the current average has risen from the previous average price target of $268.82. 
<img src="https://www.benzinga.com/files/images/story/2025/1751893303_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The standing of Travelers Companies among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$274.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$303.00</td>
<td>$290.00</td>
</tr>
<tr>
<td>Michael Phillips</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$269.00</td>
<td>$245.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$260.00</td>
<td>$247.00</td>
</tr>
<tr>
<td>David Motemaden</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$296.00</td>
<td>$288.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$290.00</td>
<td>$274.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$280.00</td>
<td>$287.00</td>
</tr>
<tr>
<td>Yaron Kinar</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$270.00</td>
<td>$265.00</td>
</tr>
<tr>
<td>Brian Meredith</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$267.00</td>
<td>$270.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$274.00</td>
<td>$286.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$247.00</td>
<td>$225.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Travelers Companies. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Travelers Companies compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Travelers Companies's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Travelers Companies's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/TRV/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Travelers Companies analyst ratings.</a>
<h2>Get to Know Travelers Companies Better</h2>
Travelers offers a broad product range and participates in both commercial and personal insurance lines. Its commercial operations offer a variety of coverage types for companies of any size but concentrate on serving midsize businesses. Its personal lines are roughly evenly split between auto and homeowners insurance.
<h3>A Deep Dive into Travelers Companies's Financials</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Travelers Companies's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 5.18%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 3.32%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Travelers Companies's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 1.4%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Travelers Companies's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.29%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a below-average debt-to-equity ratio of 0.28, Travelers Companies adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Basics of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where Travelers Companies Stands With Analysts

Press Releases

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Intellia Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - NTLA

Legal

Intellia Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – NTLA

Lawsuit for Investors in shares of Intellia Therapeutics, Inc. (NASDAQ: NTLA) announced by the Shareholders Foundation

Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2025 Earnings and Company Updates

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Intellia Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Company Progress

Health Care

Intellia Announces Positive Two-Year Follow-Up Data from Ongoing Phase 1 Study of Nexiguran Ziclumeran (nex-z), in Patients with Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy at Peripheral Nerve Society Annual Meeting

INTELLIA ALERT: Bragar Eagel & Squire, P.C. is Investigating Intellia Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema (HAE) at the European Academy of Allergy and Clinical Immunology Congress

Comments

Intellia Therapeutics

Noticias

Últimas noticias sobre Intellia Therapeutics (NASDAQ:NTLA) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL